A CVC masterclass from Bill Taranto, Founder and President of Merck’s Global Health Innovation Fund, a $600M fund that is considered one of the most impactful corporate venture funds in the world. Bill has over 20 years of healthcare investing and is focused on digital health companies transforming the future of care. Bill was just named to the Global Corporate Venturing Power List for the 14th time. We talk about the dual mandate to predict and prepare as well as the unique structure he has created which includes multiple levers like accelerators, studios, the growth equity fund, and a private equity roll-up function. We talk about the right relationship with the corporate parent, flying too close to the sun in the strategic/financial balance and why communication is often what determines success and makes innovation tangible for large organizations.
